InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
82.85
(
1.06%
)
Bitcoin
69,588.42
(
1.57%
)
Post# of 251943
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 829
Posts 119691
Boards Moderated 16
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 149935

Thursday, 12/13/2012 7:26:53 PM

Thursday, December 13, 2012 7:26:53 PM

Post# of 251943
PFE/LPTN drop PEDigree phase-1b study of iSONEP in wet-AMD patients with pigment epithelial detachment:

http://www.sec.gov/Archives/edgar/data/1251769/000110465912083334/a12-29037_18k.htm

The companies will continue to conduct a phase-2 study in second-line wet AMD that restarted (after a clinical hold due to fill/finish contamination) in Oct 2012 (#msg-80178711).

I’ve previously expressed doubt about the PFE/LPTN collaboration in AMD, which was inked in 2010 (#msg-57985240); however, LPTN’s enterprise value of only $50M makes it somewhat appealing as a trade.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up